NPPB and AL amyloidosis: Subsequently, Kastritis et al.55 showed that the post-treatment NT-proBNP (and BNP) response independently predicted survival in 94 patients with AL amyloidosis treated with bortezomib (Bor) or Bor plus dexamethasone (BDex).